Featured Research

from universities, journals, and other organizations

Crucial hour to prevent fatal bleeding

Date:
March 25, 2011
Source:
London School of Hygiene & Tropical Medicine (LSHTM)
Summary:
An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a new study suggests.

An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a study by researchers at the London School of Hygiene & Tropical Medicine suggests.

New analysis of the CRASH-2 trial shows that rapid treatment -- preferably within an hour of injury -- dramatically cuts bleeding deaths in injured patients.

The discovery, published in The Lancet, has already led to the British military using the therapy in the first hour to treat wounded soldiers in Afghanistan.

According to the scientists, to ensure that trauma patients benefit from the crucial early treatment, the NHS may need to consider giving tranexamic acid in ambulances.

If treatment is delayed beyond three or four hours after the injury, it is unlikely to be effective and might even be harmful, the research shows.

The researchers, led by Professor Ian Roberts, said: "These results show that early administration of tranexamic acid is critical -- they have major implications for trauma care provision worldwide."

The CRASH-2 trial involved 20,211 adult trauma patients in 40 countries with, or at risk of, significant bleeding who were randomly assigned to either tranexamic acid or a placebo within eight hours of injury.

First published in The Lancet last June, the trial found that administration of tranexamic acid -- which reduces clot breakdown and is used to treat heavy periods -- reduced mortality by around 10%.

However, in the latest analysis, the authors looked at subgroups of patients who had received tranexamic acid within an hour of the injury; between one and three hours; or more than three hours, in order to explore the relationship between timing of administration of the drug and its effect.

Early treatment (within an hour of injury) reduced the risk of death due to bleeding by more than 30%. Treatment given between one and three hours cut the risk of bleeding death by 20% but there was no benefit if treatment was delayed beyond 3 or 4 hours.

Professor Roberts said: "In patients with severe bleeding whether from accidents or violence, rapid treatment with tranexamic acid is vital -- an hour could mean a lifetime."


Story Source:

The above story is based on materials provided by London School of Hygiene & Tropical Medicine (LSHTM). Note: Materials may be edited for content and length.


Journal Reference:

  1. The CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. The Lancet, March 24, 2011; 377 DOI: 10.1016/S0140-6736(11)60278-X

Cite This Page:

London School of Hygiene & Tropical Medicine (LSHTM). "Crucial hour to prevent fatal bleeding." ScienceDaily. ScienceDaily, 25 March 2011. <www.sciencedaily.com/releases/2011/03/110323214400.htm>.
London School of Hygiene & Tropical Medicine (LSHTM). (2011, March 25). Crucial hour to prevent fatal bleeding. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/03/110323214400.htm
London School of Hygiene & Tropical Medicine (LSHTM). "Crucial hour to prevent fatal bleeding." ScienceDaily. www.sciencedaily.com/releases/2011/03/110323214400.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins